Evommune Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| EQT FUND MANAGEMENT S.A R.L. | 08/13/2026 | 5.29 M | $70.28 M | 7.28% | 14.63% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 3.49 M | $46.44 M | 0.00% | 9.67% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.94 M | $25.80 M | 73.45% | 5.37% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 1.93 M | $25.61 M | 0.00% | 5.33% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.55 M | $23.37 M | 6.42% | 4.30% |
| RTW INVESTMENTS, LP | 08/14/2026 | 1.50 M | $19.96 M | 0.00% | 4.16% |
| NAN FUNG GROUP HOLDINGS LTD | 08/13/2026 | 1.44 M | $19.15 M | 0.00% | 3.99% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 1.44 M | $19.07 M | 3,823.36% | 3.97% |
| ANDERA PARTNERS | 07/22/2026 | 1.39 M | $18.50 M | -26.64% | 3.85% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 1.21 M | $16.07 M | 0.00% | 3.35% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 1.00 M | $13.29 M | 100.00% | 2.77% |
| JUPITER TOPCO LLC | 08/14/2026 | 896.70 K | $11.92 M | 100.00% | 2.48% |
| BLACKROCK, INC. | 08/07/2026 | 886.54 K | $11.78 M | 31.62% | 2.45% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 881.90 K | $11.72 M | 93.80% | 2.44% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 847.39 K | $11.26 M | 0.00% | 2.35% |
| DEFILADE CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 793.15 K | $10.54 M | 16.88% | 2.19% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 755.02 K | $10.03 M | 53.17% | 2.09% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 704.43 K | $9.36 M | -3.02% | 1.95% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 500.10 K | $6.65 M | 100.00% | 1.38% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 457.02 K | $6.07 M | 100.00% | 1.26% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 451.26 K | $6.00 M | 1.12% | 1.25% |
| UBS GROUP AG | 08/13/2026 | 413.55 K | $5.50 M | 38.60% | 1.14% |
| FEDERATED HERMES, INC. | 08/12/2026 | 325.00 K | $4.32 M | 0.00% | 0.90% |
| GREAT POINT PARTNERS LLC | 08/14/2026 | 325.00 K | $4.32 M | 0.00% | 0.90% |
| FREESTONE GROVE PARTNERS LP | 08/14/2026 | 306.33 K | $4.07 M | -9.18% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 301.76 K | $4.01 M | 21.38% | 0.84% |
| STATE STREET CORP | 09/22/2026 | 293.52 K | $3.90 M | 63.51% | 0.81% |
| MORGAN STANLEY | 08/13/2026 | 290.17 K | $3.86 M | 1,057.46% | 0.80% |
| JANE STREET GROUP, LLC | 08/14/2026 | 232.44 K | $3.09 M | 100.00% | 0.64% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 193.00 K | $2.56 M | 25.06% | 0.53% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 180.00 K | $2.39 M | 80.00% | 0.50% |
| BARCLAYS PLC | 08/14/2026 | 178.73 K | $2.38 M | 8,935.89% | 0.49% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 174.46 K | $2.32 M | 219.06% | 0.48% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 170.00 K | $2.26 M | 100.00% | 0.47% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 165.90 K | $2.20 M | 100.00% | 0.46% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 161.00 K | $2.14 M | 100.00% | 0.45% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 133.35 K | $1.77 M | 5,961.36% | 0.37% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 133.07 K | $1.77 M | 40.15% | 0.37% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 133.07 K | $1.77 M | 100.00% | 0.37% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 119.93 K | $1.59 M | 96.62% | 0.33% |
| NEXTBIO CAPITAL MANAGEMENT LP | 08/14/2026 | 119.06 K | $1.58 M | -35.31% | 0.33% |
| LMR PARTNERS LLP | 08/14/2026 | 118.44 K | $1.57 M | 100.00% | 0.33% |
| LONGAEVA PARTNERS L.P. | 08/14/2026 | 116.61 K | $1.55 M | 100.00% | 0.32% |
| HOLOCENE ADVISORS, LP | 08/14/2026 | 111.13 K | $1.48 M | 100.00% | 0.31% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 104.04 K | $1.38 M | -43.48% | 0.29% |
| NORTHERN TRUST CORP | 08/13/2026 | 101.40 K | $1.35 M | 27.14% | 0.28% |
| SEVEN GRAND MANAGERS, LLC | 08/14/2026 | 90.57 K | $1.20 M | -45.00% | 0.25% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 88.20 K | $1.17 M | 21.52% | 0.24% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 87.02 K | $1.16 M | -4.82% | 0.24% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 75.00 K | $996.75 K | 100.00% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Evommune Inc. institutional Ownership - FAQ's
During the previous two years, 128 institutional investors and hedge funds held shares of Evommune Inc.. The most heavily invested institutionals were:
EQT Fund Management S.a r.l.: 5.29 M
RA CAPITAL MANAGEMENT, L.P.: 3.49 M
PRICE T ROWE ASSOCIATES INC /MD/: 1.94 M
Pivotal bioVenture Partners Investment Advisor LLC: 1.93 M
JPMORGAN CHASE & CO: 1.55 M
RTW INVESTMENTS, LP: 1.5 M
96.08% of Evommune Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 36.12 M shares in the last 24 months. This purchase volume represents approximately $889.60 M in transactions.